Frontida Biopharm Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Frontida Biopharm

Access the complete profile.

Frontida Biopharm Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Additional NAICS Codes	325412 Pharmaceutical Preparation Manufacturing
Address	1100 Orthodox Street Philadelphia, PA 19124

Note: Revenues for privately held companies are statistical evaluations.


Frontida Biopharm's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Frontida Biopharm's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Frontida Biopharm is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Frontida Biopharm Annual Revenue and Growth Rate

Frontida Biopharm	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Frontida Biopharm's revenues are gauged from an analysis of company filings.

Frontida Biopharm's Income Statement (based on Industry Averages)

Frontida Biopharm P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Frontida Biopharm is developing and marketing. Frontida Biopharm doesn't have any recent trademark applications, indicating Frontida Biopharm is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
CAT.ONE Scientific laboratory services	07/20/2015
URL PHARMPRO Manufacturing of pharmaceuticals to the order and specification of others; custom manufacturing of pharmaceuticals for packaging and sale to the order and specification of others using specific equipment and an ordered process	08/13/2009
PHARMPRO Processing of pharmaceuticals for others, namely, utilizing specific equipment and an ordered process to prepare the pharmaceutical for packaging and sale	04/25/2001

See all trademarks and details in the Full Report.

Market Share of Frontida Biopharm's Largest Competitors

A competitive analysis shows these companies are in the same general field as Frontida Biopharm, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Frontida Biopharm. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
GLAXOSMITHKLINE	Philadelphia, PA	100
AKORN OPERATING COMPANY LLC DBA AKORN	Philidelphia, PA	6
LANNETT	Philadelphia, PA	4
ADAPTIMMUNE	Philadelphia, PA	3
FRONTIDA BIOPHARM	Philadelphia, PA	2
VINTA BIO	Philadelphia, PA	1

Future Competition: Frontida Biopharm's Fastest Growing Competitors

These companies are in the same general field as Frontida Biopharm and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)